Metro · PA

GLP-1 telehealth in Philadelphia

Philadelphia anchors one of the strongest academic-medicine markets in the Mid-Atlantic, with Penn Medicine, Jefferson, and Temple producing meaningful obesity-medicine subspecialty availability. Pennsylvania's commercial-insurance environment supports relatively broad GLP-1 coverage under approved indications.

Top providers serving Philadelphia

NexLife
Flat-rate compounded GLP-1 with full pharmacy disclosure
96
/100
Ro Body
Established brand, dual compounded + brand-name routes
86
/100
Form Health
Obesity-medicine MDs, insurance-leveraged
73
/100

State context: Pennsylvania

Pennsylvania State Board of Medicine licensure required.

No state-specific compounding rules materially affecting GLP-1 access.

Read the full Pennsylvania state page →